"The pandemic has led to a greater trust of government in vaccine manufacturers and it is now open to working with manufacturers. India should create a strong network for clinical trials, which can be used for fast recruitment of patients for trials in a short time," Dr Kang said.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/iGDJpX9
0 Comments